The oncology CDMO market is expanding rapidly as rising cancer prevalence fuels demand for specialized outsourcing in drug development and manufacturing. Growing adoption of antibody-drug conjugates, cell and gene therapies, and AI-driven efficiencies is accelerating market growth, with North America leading and Asia Pacific emerging as the fastest-growing region
The global vaccine CDMO market size accounted for USD 5.09 billion in 2025 and is forecasted to hit around USD 11.16 billion by 2034, representing a CAGR of 9.10% from 2025 to 2034. The North America market size was estimated at USD 2.10 billion in 2024 and is expanding at a CAGR of 9.24% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global autologous stem cell and non-stem cell based therapies market size is calculated at USD 9.64 billion in 2025 and is forecasted to reach around USD 25.78 billion by 2034, accelerating at a CAGR of 11.55% from 2025 to 2034. The North America market size surpassed USD 3.46 billion in 2024 and is expanding at a CAGR of 11.68% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global predictive genetic counselling market size is calculated at USD 3.18 billion in 2025 and is forecasted to reach around USD 8.43 billion by 2034, accelerating at a CAGR of 11.45% from 2025 to 2034. The North America market size surpassed USD 1.23 billion in 2024 and is expanding at a CAGR of 11.55% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global infectious disease vaccines market size is calculated at USD 38.83 billion in 2025 and is forecasted to reach around USD 72.40 billion by 2034, accelerating at a CAGR of 7.17% from 2025 to 2034. The Asia Pacific market size surpassed USD 12.61 billion in 2024 and is expanding at a CAGR of 7.23% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global gene editing & mRNA tool kits market continues to expand, supported by CRISPR breakthroughs and mRNA-based therapeutic tools. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global C5 complement inhibitors market size is calculated at USD 4.85 billion in 2025 and is forecasted to reach around USD 16.01 billion by 2034, accelerating at a CAGR of 14.18% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The high-potency API (HPAPI) CDMO market is growing rapidly due to rising demand for oncology and targeted therapies. Contract manufacturers are expanding specialized facilities to meet stringent safety and regulatory standards. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global GLP-1 analogues market size accounted for USD 66.48 billion in 2025 and is forecasted to hit around USD 879.90 billion by 2034, representing a CAGR of 33.24% from 2025 to 2034. The North America market size was estimated at USD 19.96 billion in 2024 and is expanding at a CAGR of 33.41% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global liquid nefopam hydrochloride market is evolving with new applications in acute pain treatment and enhanced drug delivery systems. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global aseptic fill-finish manufacturing market size is calculated at USD 6.48 billion in 2025 and is forecasted to reach around USD 14.01 billion by 2034, accelerating at a CAGR of 8.94% from 2025 to 2034. The North America market size surpassed USD 2.12 billion in 2024 and is expanding at a CAGR of 9.05% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global scalp micropigmentation services market size is calculated at USD 2.80 billion in 2025 and is forecasted to reach around USD 4.88 billion by 2034, accelerating at a CAGR of 6.37% from 2025 to 2034. The North America market size surpassed USD 1.88 billion in 2024 and is expanding at a CAGR of 6.52% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global pressure guidewires market size is calculated at USD 621.86 million in 2025 and is forecasted to reach around USD 1,293.34 million by 2034, accelerating at a CAGR of 8.48% from 2025 to 2034. The North America market size surpassed USD 240.86 million in 2024 and is expanding at a CAGR of 8.60% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global fractional flow reserve market size accounted for USD 1.06 billion in 2025 and is forecasted to hit around USD 2.37 billion by 2034, representing a CAGR of 9.34% from 2025 to 2034. The North America market size was estimated at USD 388.86 billion in 2024 and is expanding at a CAGR of 9.48% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The next-generation RNA therapeutics market is advancing rapidly with innovations in RNA-based drugs targeting cancer, genetic disorders, and infectious diseases, driving strong growth and adoption. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global real-time location systems market size is calculated at USD 6.49 billion in 2025 and is forecasted to reach around USD 45.13 billion by 2034, accelerating at a CAGR of 24.05% from 2025 to 2034. The North America market size surpassed USD 1.88 billion in 2024 and is expanding at a CAGR of 24.24% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global myopia treatment devices market size is calculated at USD 19.49 billion in 2025 and is forecasted to reach around USD 38.51 billion by 2034, accelerating at a CAGR of 7.86% from 2025 to 2034. The Asia Pacific market size surpassed USD 7.23 billion in 2024 and is expanding at a CAGR of 7.99% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The psoriatic arthritis therapeutics drugs market is witnessing strong growth driven by increasing prevalence, advancements in biologics, and rising adoption of targeted therapies. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global hyaluronic acid personal care products market size accounted for USD 3.92 billion in 2025 and is forecasted to hit around USD 8.34 billion by 2034, representing a CAGR of 8.74% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global flexible electronics in healthcare market size is calculated at USD 8.40 billion in 2025 and is forecasted to reach around USD43.57 billion by 2034, accelerating at a CAGR of 20.70% from 2025 to 2034. The Asia Pacific market size surpassed USD 2.80 billion in 2024 and is expanding at a CAGR of 20.21% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global glycyrrhiza glabra licorice root extract market size is calculated at USD 2.28 billion in 2025 and is forecasted to reach around USD 3.87 billion by 2034, accelerating at a CAGR of 6.05% from 2025 to 2034. The Asia Pacific market size surpassed USD 1.01 billion in 2024 and is expanding at a CAGR of 6.18% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global vitamin B-complex ingredients market size is calculated at USD 3.49 billion in 2025 and is forecasted to reach around USD 5.01 billion by 2034, accelerating at a CAGR of 4.11% from 2025 to 2034. The North America market size surpassed USD 1.17 billion in 2024 and is expanding at a CAGR of 4.29% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global reusable laparoscopic instruments market size is calculated at USD 3.49 billion in 2025 and is forecasted to reach around USD 6.28 billion by 2034, accelerating at a CAGR of 6.74% from 2025 to 2034. The North America market size surpassed USD 1.31 billion in 2024 and is expanding at a CAGR of 6.85% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global rifaximin market size is calculated at USD 2.04 billion in 2025 and is forecasted to reach around USD 5.09 billion by 2034, accelerating at a CAGR of 10.72% from 2025 to 2034. The North America market size surpassed USD 736.00 million in 2024 and is expanding at a CAGR of 10.85% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global non-sterile liquids and suspensions market size is calculated at USD 51.46 million in 2025 and is forecasted to reach around USD 95.25 million by 2034, accelerating at a CAGR of 7.08% from 2025 to 2034. The North America market size surpassed USD 17.78 million in 2024 and is expanding at a CAGR of 7.23% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
+1 804 441 9344
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com